IL-1 therapy advancements are transforming the Arcalyst (Rilonacept) Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Arcalyst (rilonacept) Market Evolve From 2026 To 2030?

The market valuation for arcalyst (rilonacept) has experienced robust growth over the past few years. It is forecast to increase from $0.24 million in 2025 to $0.26 million in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. This historical expansion can be attributed to various factors such as the identification of IL-1 driven diseases, the limited availability of alternatives for rare inflammatory conditions, the strong clinical outcomes demonstrated by rilonacept, successful regulatory approvals for orphan indications, and the increasing adoption of biologic therapies by specialists.

The arcalyst (rilonacept) market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $0.33 million by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This projected growth is driven by factors such as an increase in the diagnosis of autoinflammatory syndromes, the broadening of its use into new indications, advancements in genetic screening, enhanced accessibility to biologic therapies, and a surge in investments for rare disease treatments. Key developments expected during this forecast period involve the increasing uptake of IL-1 blocking therapies, greater application in rare autoinflammatory conditions, the evolution of long-term inflammation management solutions, a sharpened focus on inhibiting specific cytokines, and better overall disease management for chronic inflammatory conditions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19877&type=smp

What Major Drivers Are Influencing Demand In The Arcalyst (rilonacept) Market?

The escalating need for personalized medicines is projected to propel the expansion of the arcalyst (rilonacept) market. This medical strategy customizes treatment and healthcare decisions according to each patient’s unique attributes, such as their genetic makeup, environment, and lifestyle. The increasing need for personalized medicine stems from its capacity to enhance treatment efficacy, minimize undesirable side effects, and account for individual variations in disease progression and drug response. As personalized medicine becomes more widespread, improved awareness and diagnostic tools facilitate the identification of rare and genetically influenced conditions. This leads to a greater number of individuals being diagnosed with conditions treatable by Arcalyst, thereby boosting the demand for the medication. For example, a report from the US-based non-profit Personalized Medicine Coalition (PMC) in February 2024 indicated that the FDA sanctioned 16 new personalized treatments for rare disease patients in 2023, a significant rise from the six approvals in 2022. Furthermore, in February 2023, PMC noted that the FDA approved 12 new personalized medicines in 2022, marking the eighth consecutive year where personalized medicines constituted at least a quarter of all new drug approvals. Consequently, the rising demand for personalized medicines is fueling the growth of the arcalyst (rilonacept) market.

Which Segment Areas Are Covered In The Arcalyst (rilonacept) Market Analysis?

The arcalyst (rilonacept) market covered in this report is segmented –

1) By Type: Lyophilized, Liquid

2) By Indication: Cryopyrin-Associated Periodic Syndromes (CAPS), Deficiency Of Interleukin-1 Receptor Antagonist (DIRA), Other Indications

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Adult Patients, Pediatric Patients

What Key Developments And Trends Are Impacting The Arcalyst (rilonacept) Market?

Leading companies in the Arcalyst (rilonacept) market are pursuing expanded indications, such as interleukin 1 trap therapy for recurrent pericarditis, to gain a competitive edge. This therapy functions by blocking excessive IL-1 proteins, thereby reducing harmful inflammation in the body. For instance, in May 2024, US-based biopharmaceutical firm Kiniksa Pharmaceuticals secured FDA approval for Arcalyst to treat recurrent pericarditis, which involves weekly subcutaneous dosing, a dual IL 1a/IL 1ß blockade mechanism, and a favorable safety profile for extended use. Such an expansion extends Arcalyst’s potential patient base beyond its initial Cryopyrin-Associated Periodic Syndromes (CAPS) indication. Nevertheless, this wider application could lead to heightened competition, ongoing safety monitoring over time, and increased scrutiny from payors.

Which Global Companies Are Actively Competing In The Arcalyst (rilonacept) Market?

Major companies operating in the arcalyst (rilonacept) market are Regeneron Pharmaceuticals Inc., Kiniksa Pharmaceuticals Ltd.

Read the full arcalyst (rilonacept) market report here:

https://www.thebusinessresearchcompany.com/report/arcalyst-rilonacept-global-market-report-

Which Region Shows The Strongest Potential For Future Growth In The Arcalyst (rilonacept) Market?

North America was the largest region in the arcalyst (rilonacept) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arcalyst (rilonacept) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Arcalyst (rilonacept) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19877&type=smp

Browse Through More Reports Similar to the Global Arcalyst (rilonacept) Market 2026, By The Business Research Company

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Petrochemicals Market 2026

https://www.thebusinessresearchcompany.com/report/petrochemicals-market

Synthetic Emerald Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-emerald-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795